Metropolis Healthcare Ltd
NSE:METROPOLIS
Intrinsic Value
Metropolis Healthcare Ltd. owns and operates medical laboratories. [ Read More ]
The intrinsic value of one
METROPOLIS
stock under the Base Case scenario is
1 213.7
INR.
Compared to the current market price of 1 775.55 INR,
Metropolis Healthcare Ltd
is
Overvalued by 32%.
Metropolis Healthcare Ltd's market capitalization is 90.9B INR.
METROPOLIS stock price is 1 775.55 INR.
METROPOLIS stock (1 213.7 INR) is 32% less than its price (1775.55 INR).
METROPOLIS stock (496.16 INR) is 72% less than its price (1775.55 INR). Open DCF Valuation
METROPOLIS stock price (1775.55 INR) is 8% less than its Relative Value (1 931.25 INR). Open Relative Valuation
METROPOLIS has downside potential of 3% compared to the average analyst price target.
Open Wall St Estimates
METROPOLIS's ROIC (Return on Invested Capital) for the past 12 months is positive and is equal to 11%.
METROPOLIS's Revenue has dropped by 1% over the past 12 months.
METROPOLIS's ROE (Return on Equity) for the past 12 months is positive and is equal to 12%.
METROPOLIS's short-term assets (3B INR) exceed its short-term liabilties (3B INR).
METROPOLIS has positive Net Income for the last twelve months.
METROPOLIS's Revenue has been growing by 8% per year for the last 3 years.
METROPOLIS's Revenue is forecast to grow at a rate of 11% per year over the next 3 years.
METROPOLIS has positive Net Debt. This means that the company has more debt (1B INR) than cash and short-term investments (1B INR).
METROPOLIS has positive Operating Income for the last twelve months.
METROPOLIS's ROE (Return on Equity) has significantly decreased in the last 3 years from 30% to 12%.
METROPOLIS's ROIC (Return on Invested Capital) has significantly decreased in the last 3 years from 40% to 11%.
METROPOLIS has positive three-year average ROE (Return on Equity): 23%. The company is efficient at transforming stockholders' equity into net income.
METROPOLIS has very high three-year average ROIC (Return on Invested Capital): 27%. The company is very efficient at using invested capital to generate operating income.
METROPOLIS has positive Free Cash Flow for the last twelve months.
METROPOLIS generates enough operating income (2B INR) to cover interest payments on its debt (243m INR).
METROPOLIS has positive Gross Profit for the last twelve months.
METROPOLIS's long-term assets (15B INR) exceed its long-term liabilties (5B INR).
METROPOLIS's D/E (Debt to Equity) is very low and is equal to 0.11.
METROPOLIS's Altman Z-Score is very high and is equal to 12.26.
Valuation Backtest
Metropolis Healthcare Ltd
Run backtest to discover the historical profit from buying and selling
METROPOLIS
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Metropolis Healthcare Ltd
Balance Sheet Decomposition
Metropolis Healthcare Ltd
| Current Assets | 3B |
| Cash & Short-Term Investments | 1.2B |
| Receivables | 1.2B |
| Other Current Assets | 644.4m |
| Non-Current Assets | 12.1B |
| Long-Term Investments | 217.4m |
| PP&E | 3.2B |
| Intangibles | 8.3B |
| Other Non-Current Assets | 364.1m |
| Current Liabilities | 2.5B |
| Accounts Payable | 811.9m |
| Accrued Liabilities | 114.4m |
| Other Current Liabilities | 1.6B |
| Non-Current Liabilities | 2.1B |
| Long-Term Debt | 1.2B |
| Other Non-Current Liabilities | 930.1m |
Earnings Waterfall
Metropolis Healthcare Ltd
|
Revenue
|
11.6B
INR
|
|
Cost of Revenue
|
-2.4B
INR
|
|
Gross Profit
|
9.2B
INR
|
|
Operating Expenses
|
-7.4B
INR
|
|
Operating Income
|
1.8B
INR
|
|
Other Expenses
|
-566.4m
INR
|
|
Net Income
|
1.2B
INR
|
Free Cash Flow Analysis
Metropolis Healthcare Ltd
METROPOLIS Profitability Score
Profitability Due Diligence
Metropolis Healthcare Ltd's profitability score is 61/100. The higher the profitability score, the more profitable the company is.
Score
Metropolis Healthcare Ltd's profitability score is 61/100. The higher the profitability score, the more profitable the company is.
METROPOLIS Solvency Score
Solvency Due Diligence
Metropolis Healthcare Ltd's solvency score is 69/100. The higher the solvency score, the more solvent the company is.
Score
Metropolis Healthcare Ltd's solvency score is 69/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
METROPOLIS Price Targets Summary
Metropolis Healthcare Ltd
According to Wall Street analysts, the average 1-year price target for
METROPOLIS
is 1 720.67 INR
with a low forecast of 1 246.34 INR and a high forecast of 2 071.65 INR.
Shareholder Return
METROPOLIS Price
Metropolis Healthcare Ltd
| Average Annual Return | 26.83% |
| Standard Deviation of Annual Returns | 59.51% |
| Max Drawdown | -65% |
| Market Capitalization | 90.9B INR |
| Shares Outstanding | 51 226 900 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Metropolis Healthcare Ltd
Country
Industry
Market Cap
Dividend Yield
Description
Metropolis Healthcare Ltd. owns and operates medical laboratories. The company is headquartered in Gurgaon, Haryana and currently employs 4,532 full-time employees. The company went IPO on 2019-04-15. The firm offers a range of clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and monitoring of the disease. The firm also offers analytical and support services to clinical research organizations for their clinical research projects. Its services include pathology testing services, corporate wellness, lab in hospitals and clinical research services. The firm offers a range of tests and profiles that include advanced tests in diagnosis of cancer, neurological disorders, infectious diseases, and an array of genetic abnormalities. The company owns a chain of diagnostic centers across India, South Asia, Africa and the Middle East. The firm has spread its footprint across 20 Indian states and over 210 cities.
Contact
IPO
Employees
Officers
The intrinsic value of one
METROPOLIS
stock under the Base Case scenario is
1 213.7
INR.
Compared to the current market price of 1 775.55 INR,
Metropolis Healthcare Ltd
is
Overvalued by 32%.
You don't have any saved screeners yet
